Keon S. Shin

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Effects of gynosaponin TN-2 on L-DOPA-induced cytotoxicity in PC12 cells.

Effects of gynosaponin TN-2 on L-DOPA-induced cytotoxicity in PC12 cells.

Journal: Neuroreport

Published: November 10, 2017

Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA.

Gynostemma pentaphyllum Ethanolic Extract Protects Against Memory Deficits in an MPTP-Lesioned Mouse Model of Parkinson's Disease Treated with L-DOPA.

Journal: Journal of medicinal food

Published: December 23, 2016

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA.

Journal: BMC complementary and alternative medicine

Published: December 05, 2016

Effects of (-)-Sesamin on Chronic Stress-Induced Anxiety Disorders in Mice.

Effects of (-)-Sesamin on Chronic Stress-Induced Anxiety Disorders in Mice.

Journal: Neurochemical research

Published: July 25, 2016

Effects of (-)-sesamin on chronic stress-induced memory deficits in mice.

Effects of (-)-sesamin on chronic stress-induced memory deficits in mice.

Journal: Neuroscience letters

Published: July 06, 2016

L-DOPA modulates cell viability through the ERK-c-Jun system in PC12 and dopaminergic neuronal cells.

L-DOPA modulates cell viability through the ERK-c-Jun system in PC12 and dopaminergic neuronal cells.

Journal: Neuropharmacology

Published: March 04, 2015

Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Journal: BMC neuroscience

Published: January 14, 2015

Ameliorating effects of gypenosides on chronic stress-induced anxiety disorders in mice.

Ameliorating effects of gypenosides on chronic stress-induced anxiety disorders in mice.

Journal: BMC complementary and alternative medicine

Published: January 08, 2015

Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.

Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models.

Journal: Neurochemistry international

Published: July 29, 2014

Multiple treatments with L-3,4-dihydroxyphenylalanine modulate dopamine biosynthesis and neurotoxicity through the protein kinase A-transient extracellular signal-regulated kinase and exchange protein activation by cyclic AMP-sustained extracellular signal-regulated kinase signaling pathways.

Multiple treatments with L-3,4-dihydroxyphenylalanine modulate dopamine biosynthesis and neurotoxicity through the protein kinase A-transient extracellular signal-regulated kinase and exchange protein activation by cyclic AMP-sustained extracellular signal-regulated kinase signaling pathways.

Journal: Journal of neuroscience research

Published: February 22, 2014

Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson's disease.

Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson's disease.

Journal: Brain research

Published: December 23, 2013

The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells.

The roles of cyclic AMP-ERK-Bad signaling pathways on 6-hydroxydopamine-induced cell survival and death in PC12 cells.

Journal: Toxicology in vitro : an international journal published in association with BIBRA

Published: May 06, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026